Try our Advanced Search for more refined results
Life Sciences - November, 2017
320 articles
- FDA Chief Reveals New Openness To Quicker Drug Approvals
- Galena Class Settlement Must Proceed, Del. Court Says
- Idaho Doc Gets 16 Years For Illegal Opioid Prescriptions
- JPML Open To Opioid MDL Despite Concerns About Size
- Roche Drops Medical Supply Co. From $89M Test Strips Suit
- Mass. DA Wants 134 Tainted Drug Convictions Thrown Out
- NJ Panel Advances Bill To Close Loophole For Opioid Access
- Sexual Enhancement Supplements Recalled For Health Risk
- J&J Can't Escape $110M Verdict In Mo. Talc Cancer Trial
- Ariad, Investors Strike $3.5M Deal Over Cancer Drug Outlook
- The Billing Evolution: How Far Along Is Your Firm?
- 10 Tips For Effective Practice Before The 5th Circ.
- J&J Unit Workers Say Biz Knew Pelvic Mesh Device Risks
- Reckitt, Generics Makers Settle Mucinex Antitrust Case
- Atty Seeks Arbitration For Ex-Pot Co. Exec's Malpractice Suit
- Judge Tosses 24 New Complaints In Eliquis MDL
- BioChemics Obtains 11th-Hour Deposit On $17M Owed To SEC
- Pharma Marketers Can't Escape Tricare Kickback Suit
- PetSmart Beats Fraud Claims Over Prescription Cat Food
- Teamsters Files Suit Against Drug Cos. For Opioid Push
- HHS Pick Bashes ACA, Sweats Drug Prices On Capitol Hill
- Calif. Appeals Court Upholds BOE's $17M Sales Tax Reshuffle
- Pharmacies Abused Federal Workers' Comp, FCA Suit Says
- Mich. Law Bars Some Risperdal Suits, Pa. Court Finds
- Preparing Your Company Witnesses For The Gotcha Question
- The Latest Trends In Drug Monopolies
- With Wave Of Suits, Chicago Turns Focus To Residents' Rights
- Judging A Book: Saris Reviews 'Locking Up Our Own'
- J&J Moves To Duck Pfizer Suit Over Remicade Biosimilar
- J&J Unit Didn't Provide Pelvic Mesh Warning, Witness Says
- Stryker Unit Settles Biomet Trade Secret Suit
- Altor Investor Seeks Appraisal After $290M NantCell Deal
- Feds Point To Email Trove In Ex-Katten Atty Fraud Trial
- Feds Say Ex-NYU Scientist Entertained Dancer On Gov't Dime
- Pharma CEO Charged With Stealing $1.5M From Investors
- FDA Warning Wire: Issues At Pharmacy Linked To Vision Loss
- TTAB Greenlights Boehringer's 'Breathless' Trademark
- Akorn, Investors Get Initial OK For $24M Accounting Deal
- Warren Asks Trump's HHS Pick About ACA, Drug Prices
- PE-Backed Medpace Unveils 4M-Share Secondary Offering
- Deals Rumor Mill: Siemens Healthineers, Uber, Albea
- OIG Revokes Patient Charity's Kickback Liability Protection
- Allergan Hit With Antitrust Suit Over Deal With Tribe
- Fed. Circ. Guidance For Pharma Method-Of-Use Patent Cases
- The Broad Reach Of Medicare Act's Preemption Provision
- Arrested Insys Founder Kicks Off Jog-Blocking Ankle Monitor
- 'Seminal' Allergan Cases Test Copycat Drug Limits
- J&J Unit Put Pelvic Mesh Profit Over Safety, NJ Jury Told
- Shire Trade Secrets Complaint Against Ultragenyx Accelerated
- 7th Circ. Can't Find Bad Faith In Purchase Of Bacteria Co.
- Maquet Sues Abiomed Over Blood Pump Patent
- Del. Justices Reject Third Chance For BioScrip Investors
- Shkreli Mentor And Investor Says He Lied To Feds
- 3 Life Sciences Cos., 1 Bank Launch IPOs Totaling $481M
- Pfizer Wants Justices To Review Lipitor Antitrust Ruling
- Pfizer Reaches $94M Settlement Over Celebrex Claims
- 'Reckless' Adviser Doomed Copy Of Biogen Blockbuster: Suit
- Treasury, IRS Appeal Invalidation Of Anti-Inversion Rule
- DOJ Closes J&J Witness Tampering Investigation
- CR Bard Loses Bid To Escape Heart Filter MDL
- Justices Decline To Review Removal Of Vascular Filter Suits
- Shkreli Deal Legit, Investor Says Ex-Katten Atty Told Him
- No New Trial For Parents Suing Abbott Over Birth Defects
- Fed. Circ. OKs Ax Of Lilly's Axiron Patent, Allows Generics
- Ex-Virginia Tech Professor Charged In Alleged Grant Fraud
- Florida Sued For Dragging Feet On Medical Pot Licenses
- Medicis, Solodyn Buyers Duel For Quick Wins In Antitrust MDL
- Amerisource Cuts $625M FCA Deal Over Repacked Drugs
- What Attorneys Get Wrong About Native American Law
- Amicus Arguments For And Against Inter Partes Review
- Amarin Case Demonstrates Limits Of ITC Jurisdiction
- Does Your D&O Policy Really Cover Gov't Investigations?
- How Associate Bonuses May Highlight BigLaw's Profit Gap
- Akorn Reaches $24M Deal To End Investors' Accounting Suit
- Dialysis Patients Face Undoing By Experts In Fresenius MDL
- Sanofi Wins Fees After Ditching 'Clearly Frivolous' FCA Suit
- Ex-Galleon Trader Says He Didn't Report Shkreli To Feds
- DOJ Cleared To Split Up $350M Shire Deal For Whistleblowers
- FDA Warning Wire: Insomnia Drug Promo Omits Risk Info
- Pharma Groups Pressure FDA On Drug Innovation, Access
- Fla. Hospitals Launch Wide-Ranging Opioid Liability Suit
- 'Willfulness' In Civil FBAR Cases Comes Down To The Facts
- Pepper Hamilton Regains Life Sciences Duo In Philly
- Opioid Insurance Litigation Is Mounting With Mixed Results
- Ex-Galleon Trader Details Shkreli Vendetta At Ex-Katten Atty Trial
- Globus Says Ex-Engineer Took Trade Secrets To Stryker
- DOD Slow To Target Rising Rx Costs, Fraud Risks: Watchdog
- Abbvie Says Medical Mutual Being 'Cagey' In Androgel MDL
- Fed. Circ. Urged To Not Review Defense In $200M Patent Suit
- J&J Says Applicant Must Arbitrate Background Check Claims
- EU Drug Agency Packs Bags For Amsterdam Amid Brexit
- SEC Judge Refuses To Bar Shkreli Without Tie To Adviser
- Deal Expected In Insurer's Actos Cancer Suit Against Takeda
- Don't Waste This Planning Cycle: Year-End Strategies
- Mass Tort Firm Nears Settlement In $110M Contractor Suit
- Restasis Buyers Hit Allergan With Antitrust Suit
- Tribe Invokes Immunity In $10M Cannabis Contract Dispute
- CytRx Investors Seek Cert. In Suit Over Cancer Drug Trial
- Criticism Of FDA Citizen Petitions Is Often Misguided
- Hatch-Waxman And Copying: An Exception To The Exception?
- Orexigen Seeks Toss Of Suit Over Drug Trial Leaks
- Texas Justices Shelve J&J Mesh Case After Appeal Dropped
- Catheter IP Row Settles After Fed. Circ. Kills $20M Ruling
- VC-Backed Stitch Fix Ekes Gain After $120M IPO Prices Low
- Colgate Says Experts' Nix Undermines Philly Talc Case
- From Snaps To Tweets: The Craft Of Social Media Discovery
- Health Hires: Hogan Lovells, Jones Day, Morgan Lewis
- USPTO Defends Win-Or-Lose Fee Rule To Full Fed. Circ.
- Scientists See No Solution As Talc Cases Test The System
- Taxation With Representation: Andrews, Mayer, Jones, Delaby
- A Post-Lexmark Plan For Multiple Inventive Methods Of Use
- Consultant Contracts Can Create California Connection
- Tribe Seeks Injunction Against Hemp-Seizing Calif. County
- Tech Co. Must Face Suit Over Patient Monitoring System
- Gov't Asks 2nd Circ. To Toss Pfizer's $8.3M Interest Case
- NantKwest Investor Sues Insiders Over Restatements
- Shkreli Auditor Says Investor Settlements Seemed Legit
- Senate Sends $700B Defense Bill To Trump's Desk
- Insys Founder Denies Plot To Bribe Doctors Over Opioid Spray
- PTAB Chief Debunks Patent Myth As Petitions Soar
- 3rd Circ. Won't Revive FCA Suit Against CVS Caremark
- Xarelto Witness-Tampering Testimony Barred, For Now
- Pharma Trading Suspects Denied Bid To Trim Suit
- Chinese Fintech Jianpu Raises $180M After IPO Prices Low
- Chicago's Suit Over Opioids Paused Ahead Of MDL Ruling
- Consumers Get State Classes Certified In Bayer Vitamin Row
- Illinois Biometrics Privacy Suits Bring Insurance Questions
- Tobacco Groups Blast FDA For 'Massive' Speech Restriction
- FTC's Ohlhausen Sees Light At End Of Pay-For-Delay Tunnel
- House Passes Tax Bill With Deep Cuts For Businesses
- Auxilium Not Liable For Man's Heart Attack, Ill. Jury Finds
- An Interview With Former DHS Secretary Jeh Johnson
- J&J, Talc Supplier Not Liable For Woman's Asbestos Illness
- Senate Bill Targets Opioid Safety For Vets Not Treated At VA
- J&J Slammed With $247M Verdict In Texas Hip Bellwether
- Hurdles To Consider When Securing A Personnel File
- Calif.'s New Focus On Drug Pricing Transparency
- VisionAid Can't Get Own Atty In Firing Suit, 1st Circ. Says
- Auxilium's First Testosterone Bellwether Heads To Jury
- Eye-Drug Compounder Can't Dodge Allergan Suit
- Abbott Won't Face Autism Claim In Depakote Birth Defect Trial
- J&J, Bayer Fight Ex-FDA Head's Xarelto Warning Testimony
- Aveo Investors Get Certification In Cancer Drug Suit
- BioScrip Investors Ask Del. Justices For 3rd Try At Suit
- Endo Concealed Unit's Alleged Price-Fixing, Investors Say
- Bass Gets Fed. Circ. Win On Drug Patent From Sidelines
- Gov't Says High Court Should Take Up Vitamin C Price-Fix Suit
- Online Health Network Hit With $179M Judgment In FTC Probe
- Ex-Katten Atty Wanted Shkreli Loan Disclosed, Jury Hears
- 5th Circ. Won't Restore $7.5M Jury Award In Contract Suit
- Shanghai Pharma To Pay $557M For Cardinal Health China Biz
- Split PTAB Denies Pfizer's Challenge To Rituxan Patent
- GE Seeks Damages Trial After $43.8M Machine-Parts Verdict
- DC Circ. Threads Needle On Docs Privilege In FTC Row
- State AGs Want Separate Track In Generic Price-Fixing MDL
- Bipartisan Bill Would Block 340B Drug Program Cuts
- PharMerica Kickbacks Not Public Knowledge, 3rd Circ. Told
- China's FDA Reform Will Encourage Life Science Innovation
- Judging A Book: Gilstrap Reviews 'Alexander Hamilton'
- Deliberate Discovery Responses Shift Onus Onto Opponent
- Opioid Epidemic Brings Ramifications For Physicians
- Depakote Judge Denies Abbott Bid To Restrict Exec Subpoena
- Janssen, Samsung Subsidiary Drop Suit Over Remicade Copy
- 9th Circ. Urged to Let Arbitrators Get Docs From Third Parties
- Fed. Circ. Affirms Toss Of Hyptertension Treatment IP
- US House Passes Compromise $700B Defense Bill
- DOJ Fights Whistleblower 'Windfall' In $280M FCA Deal
- Feds Extend Immunity To Ex-Retrophin Exec Over Hacking Claim
- Cherokee Opioid Fight Should Inspire Other Tribes, AG Says
- Ex-FDA Commissioner Slams Xarelto Warnings In Philly Trial
- RI Atty Fights Texas Jurisdiction In Mesh Row Before Justices
- J&J Hip Implant Patients Seek Big Damages From Texas Jury
- Injectable Silicone Linked To Disfigurement, Deaths, FDA Says
- The Case For Creating A Mediation Department At Your Firm
- FDA Warns Of Deaths Linked To Opioid-Like Kratom
- Walgreens Hit With Suit Over Sale Of J&J Talc Products
- Miramar Directors Ready To Put Sientra Deal Suit To Bed
- Peruvian Food Co. Camposol Files $345M Dual-Listed IPO
- Woman Seeks $24M As Trial Over Asbestos, J&J Talc Closes
- Ex-Katten Atty Trial Rocked By Claims Of Witness' Cybercrime
- Hospitals Sue HHS Over Big Cut To 340B Drug Payments
- 3 Cos. Price IPOs Raising $410M Led By Chinese Lender
- J&J Hip Implant Jury Won't Hear Witness Tampering Claim
- Biotech Co. Wants Investors' Stock-Drop Suit Tossed
- TPP Revival Effort Leaves US Out In The Cold
- Pa. Appeals Court Upholds Risperdal Time Bar
- Fed. Circ. Clears Apotex In Neulasta Biosimilar Patent Row
- Pharma Salesman Cops To Defrauding NJ Insurance Programs
- No Damages For Promega In Gene-Testing IP Row: Fed. Circ.
- 10th Circ. Won't Revisit MusclePharm's SEC Probe Coverage
- 3 Fast Facts About Trump's Pick For HHS Chief
- Pelvic Mesh Jury Sides With J&J Unit In Houston
- Pharma Case Highlights Importance Of Unrebutted Evidence
- Key Considerations Before Leasing To Cannabis Businesses
- How Tax Reform Could Impact The Health Care Industry
- OvaScience Can't Duck IVF Treatment Suit, Shareholders Say
- Being There: Defending Depositions
- Trump Taps Vet Of BigLaw, Big Pharma As Next HHS Chief
- Endo Cert Bid Calls AGs' Use Of Private Attys Unconstitutional
- Grading Gottlieb: How Attys View FDA Chief's First 6 Months
- Retrophin CEO Says He Was Suspicious Of Ex-Katten Atty
- Allergan Can't Nix Antitrust Row As Buyer Class Is Certified
- Fed. Circ. Upholds Sanofi Win Over Generics In Multaq Suit
- Ex-Aveo Exec's Penalty In SEC Deal Up To Magistrate Judge
- Fla. Compounding Pharmacy Ducks Whistleblower's FCA Suit
- 9 Firms To Steer IPOs Exceeding $1.7B Amid Preholiday Rush
- A Tale Of 2 Cases On 3rd-Party Releases
- NY Agency Ordered To OK Speech Device For Disabled Girl
- BakerHostetler Hires Ex-Stroock Patent Partner In NY
- Janssen, Gilead Clear Mylan To Sell Generic HIV Drug
- Pa. County Launches Opioid Marketing RICO Suit
- The Legal Fallout For Harvey Weinstein's Hired Hands
- Actavis Ruling Bolsters Insurers In Opioid Coverage Battles
- Feds Fight Ex-Katten Atty's Effort To Savage Accountant
- Amneal Gets OxyContin Patent Nixed At PTAB
- Drinker Biddle Comms Keep Privilege In J&J Tampering Probe
- Affiliate Drug Discount Exempt From Antitrust Law, FTC Says
- Contentious Acquisition Changes Stay In Final Defense Bill
- Metropolitan Bank Leads 4 IPOs Totaling $372M
- DOJ Wins Bid To Halt Insider Trading Suit Against Doc
- Colo. Pot Company Fights IRS Power At Supreme Court
- Pa. Judge OKs Deposition In Xarelto Witness Tampering Row
- Jury Persuasion In An 'Alt-Fact' World
- 'End The Shenanigans,' FDA Chief Tells Big Pharma
- Arena Pharma, Investors Strike $24M Deal In Diet Drug Suit
- Russia Floats Conditions To Approve Bayer-Monsanto Deal
- Big Pharma Faces Insurance Hurdles In Opioid Suits
- Vet, Pharmacy Convicted Of Selling Opioid For Racehorses
- Investors Spar Over Damages In Valeant, Pershing Rows
- Radiation, Not J&J Talc, Caused Woman's Cancer, Jury Told
- Investor Says No Sham Deal Talks With Ex-Shkreli Atty
- Florida Time Share Co., Others Launch IPOs Totaling $336M
- Pharma Co. Behind Fentanyl Spray Seeks Out Of Investor Suit
- Heart Attack Not Worth Testim's Benefits, Patient Testifies
- Xarelto Trial Attys Spar Over Witness Tampering Accusations
- Allergan Making A 'Mockery' Of IPR Process, Lawmaker Says
- FDA Warning Wire: Salmonella At Food Plant
- Medtronic, Others Beat Catheter IP Suits With TC Heartland
- Actavis Not Owed Opioid Defense, Calif. Appeals Court Says
- Pillsbury Lands Ex-Latham Deal Pro In NY
- Al Jazeera Says MLBers Must Subpoena Journo In Libel Suit
- Deals Rumor Mill: Providence, Blackstone, Louis Dreyfus
- J&J Job Candidate Must Arbitrate Claims Against Recruiter
- Applying The Investors' Playbook To Legal Career Planning
- 'Asbestos' In J&J Talc Was False Positive, Jury Told
- Shkreli Investors Recount Few Dealings With Ex-Katten Atty
- Allergan Hit With Securities Suit Over Generics Price-Fixing
- Auxilium Ignored FDA's Limits On Testim's Use, Jury Told
- VC-Backed Stitch Fix Joins 6 IPO Launches Totaling $855M
- Janssen, Bayer Rigged Xarelto Trial, Philly Jury Hears
- Bayer Urges High Court To Deny Dow Appeal Of $455M Award
- Feds Fight Kimberly-Clark's Bid To Have FCA Suit Tossed
- Kentucky AG Sues Endo For Alleged Role In Opioid Crisis
- Medical Device Co. Accused Of Infringing RFID Patent
- The Law Firms Spinning The White House Turnstile
- Genocea Hit With Securities Suit After Herpes-Drug Flop
- Has Trump Been Good For BigLaw?
- Who's Repping Whom? Law360's Guide To The Mueller Probe
- What Trump's War On Regulations Means For Lawyers
- Valeant Sells Female Libido Drug Biz Amid Shareholder Suit
- IBio Sues German Research Co. In Widened IP Dispute
- J&J Talc Litigation Roundup
- Families Want Zofran MDL Paused To Beef Up Suit
- Demystifying Inherent Obviousness
- How IT And Procurement Pros Can Inform Law Firm Budgeting
- Pharma Cos. Can't Dodge Lidoderm Buyers' Antitrust MDL
- Ex-ArthroCare CEO Gets 20 Years For $750M Fraud
- Fed. Circ. Backs PTAB On Nixed Claims In Univ. Of Md. Patent
- DePuy Can't Block Ex-Employee's Work For Competitor
- Feds Say Pharma Trading Suspects Can't Get Early Win
- AbbVie Says Evidence Doesn't Back $140M AndroGel Verdict
- Janssen, Marketing Co. Can't Escape TCPA Suit After Spokeo
- 10 Firms To Steer IPOs Raising Near $2B As China Leads Way
- Xarelto User Faces Hard Sell In 1st Philly Mass Tort Trial
- Zoll Says Philips Can't Add $4M Interest To Patent Win
- FDA To Target Addictive Properties Of Opioids, Cigarettes
- Deals Rumor Mill: Broadcom, CVS, Belfius
- Feds Accuse Biotech Co., Execs Of 'Wide-Ranging Fraud'
- Auxilium Bellwether Latest Test For Testosterone Therapy Ads
- Alcon Must Show Exec Emails With Doc In Contact Lens MDL
- Health Hires: Jackson Lewis, EBG, Spencer Fane, AMRI
- NY Doc, Nurse Arrested For $2M Opioid Prescription Scheme
- Taxation With Representation: Skadden, Davis, Kirkland
- Bracing For A Life Sciences Enforcement Zeitgeist: Part 2
- Getting Real About Artificial Intelligence At Law Firms
- No Trace Of Mesothelioma In J&J Talc Miners, Jury Told
- Witness Left Firm Of Ex-Katten Atty's Relative, Jury Hears
- Covidien Fights Ex-Worker's Bid To Pause Contract Suit
- Drug Cos. Urge 3rd Circ. To Rethink Eye Drop Suit Ruling
- PE-Backed Evoqua Water Leads 4 IPOs Totaling $777M
- Deals Rumor Mill: T-Mobile, Novartis, TMF Group
- Philly Xarelto Warning Claims Not Preempted, Judge Rules
- FTC Notes Decline In Pay-For-Delay Drug Patent Settlements
- AIA Reviews Help Lower Drug Prices, High Court Hears
- Ex-Pharma Exec Admits Insider Trading On Cancer Drug Info
- Liberty Win Widens Split On SEC Probe Costs, 10th Circ. Told
- J&J Wins OK For $7M Aveeno Natural Labeling Settlement
- PE Shop Aisling Closes $280M Medical Therapies Fund
- AmerisourceBergen Eyes $575M FCA Deal After Criminal Plea
- Bracing For A Life Sciences Enforcement Zeitgeist: Part 1
- Proportionality, Not Perfection, Is What Matters
- Janssen Must Fork Over More Employee Info In Opioid Suit
- Investor Denies Contact With Ex-Katten Atty Before Deal
- Fed. Circ. Axes Bayer ED Drug Patent, Reversing Lower Court
- DAs Say 6,000 Cases Tied To Disgraced Drug Lab Chemist
- Hospitals Vow To Sue CMS Over Slashed 340B Reimbursement
- Gilead, Investors Dissect Word In $50M Drug Bonus Fight
- Ky. Sues Law Firm To Recover $4.2M From Oxycontin Deal
- Teva Beats Patent Claims Over Uceris Generic
- J&J Talc Plaintiff Wants 2nd Shot At Reviving $72M Award
- $20M Mexican Nutraceutical Row To Go To Arbitration
- Chuck Norris, Wife Say MRI Drug Threatened Her Life
- FDA Warns 4 Cos. On Pot Compound Cancer Claims
- Fed. Circ. Upholds Ruling That FluMist Didn't Kill Child
- White House Panel Urges Sweeping Action On Opioid Crisis
- Investors Say Perrigo Overpromised To Dodge Mylan Takeover
- Alaska, Ohio City Latest To Sue Over Opioid Marketing
- Deals Rumor Mill: Novartis, I-Med Radiology, Kaltura
- Fed. Circ. Clarifies Law For Functional Antibody Claims
- Make Way For The 'Unicorns'